A review of basal insulins.
Chantelau
E
E
D000818:Animals; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D009369:Neoplasms / Q000139:chemically induced; D051381:Rats
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D007334:Insulin-Like Growth Factor I